Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure



Rating:

Share or cite this content

Citations should be made in the following way:
M. Barik (Wakefield, United Kingdom), A. Sawant (Wakefield, United Kingdom). Importance of admission biomarkers in prognostication of  patients with SARS-Cov-2. 910

Member's Comments

No comment yet.

Related content which might interest you: Determining the best diagnostic biomarker for sepsis and prognosis assessment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011 Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Blood biomarker algorithms to guide COPD assessment and risk stratification Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Course 2016 Year: 2016 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Clinical diagnosis, monitoring and biomarkers in ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Usefulness of GDF-15 as a biomarker of respiratory worsening in COVID-19 patients. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality. Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Usefulness of the ILD-GAP index in predicting COVID-19 pneumonia prognosis Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Biomarkers for clinical management Source: International Congress 2017 – PG12 Life-threatening pulmonary infections Year: 2017 Prognostic indices for COPD patient management: how many do we need? Source: Eur Respir J 2011; 39: 223-224 Year: 2012 Prognostic indices for COPD patient management: how many do we need? Source: Eur Respir J 2012; 39: 223-224 Year: 2012 Application of biomarkers and patient characteristics to personalize asthma treatment for children Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma Year: 2016 The clinical and prognostic evaluation of patients with PAH Source: Annual Congress 2012 - Exercise testing in pulmonary arterial hypertension patients Year: 2012 Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005 Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011